MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 187 filers reported holding MEDICINES CO in Q1 2015. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,198,000 | -92.3% | 25,879 | -95.5% | 0.01% | -92.4% |
| Q3 2019 | $28,586,000 | +33.6% | 571,713 | -2.5% | 0.13% | +37.5% |
| Q2 2019 | $21,394,000 | +67.9% | 586,611 | +28.6% | 0.10% | +68.4% |
| Q1 2019 | $12,745,000 | +284.0% | 456,004 | +163.0% | 0.06% | +280.0% |
| Q4 2018 | $3,319,000 | -51.6% | 173,417 | -24.4% | 0.02% | -42.3% |
| Q3 2018 | $6,861,000 | +6.6% | 229,393 | +30.9% | 0.03% | 0.0% |
| Q2 2018 | $6,434,000 | -46.0% | 175,306 | -51.5% | 0.03% | -44.7% |
| Q1 2018 | $11,910,000 | +20.5% | 361,553 | -0.0% | 0.05% | +27.0% |
| Q4 2017 | $9,887,000 | -29.8% | 361,635 | -5.0% | 0.04% | -33.9% |
| Q3 2017 | $14,094,000 | -4.3% | 380,520 | -1.8% | 0.06% | -5.1% |
| Q2 2017 | $14,724,000 | -39.6% | 387,381 | -22.3% | 0.06% | -41.6% |
| Q1 2017 | $24,365,000 | +51.8% | 498,254 | +5.4% | 0.10% | +36.5% |
| Q4 2016 | $16,049,000 | -11.9% | 472,853 | -2.0% | 0.07% | -14.9% |
| Q3 2016 | $18,208,000 | +42.4% | 482,458 | +26.9% | 0.09% | +35.9% |
| Q2 2016 | $12,789,000 | +8.8% | 380,294 | +2.8% | 0.06% | +10.3% |
| Q1 2016 | $11,751,000 | -9.5% | 369,874 | +6.3% | 0.06% | -9.4% |
| Q4 2015 | $12,987,000 | -5.1% | 347,793 | -3.6% | 0.06% | -11.1% |
| Q3 2015 | $13,692,000 | +30.4% | 360,704 | -1.7% | 0.07% | +35.8% |
| Q2 2015 | $10,503,000 | +2.8% | 367,121 | +0.7% | 0.05% | +1.9% |
| Q1 2015 | $10,218,000 | +20.3% | 364,654 | +18.8% | 0.05% | +20.9% |
| Q4 2014 | $8,495,000 | +36.1% | 307,007 | +9.8% | 0.04% | +43.3% |
| Q3 2014 | $6,242,000 | -14.8% | 279,678 | +10.9% | 0.03% | -16.7% |
| Q2 2014 | $7,328,000 | +15.0% | 252,159 | +12.5% | 0.04% | +20.0% |
| Q1 2014 | $6,372,000 | -23.3% | 224,226 | +4.2% | 0.03% | -21.1% |
| Q4 2013 | $8,311,000 | +12.3% | 215,194 | -2.6% | 0.04% | +5.6% |
| Q3 2013 | $7,402,000 | -19.4% | 220,837 | -26.0% | 0.04% | -23.4% |
| Q2 2013 | $9,178,000 | – | 298,360 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |